Cargando…
Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906640/ https://www.ncbi.nlm.nih.gov/pubmed/33617779 http://dx.doi.org/10.1016/S2213-8587(21)00028-0 |
_version_ | 1783655332302553088 |
---|---|
author | Brix, Thomas H Hegedüs, Laszlo Hallas, Jesper Lund, Lars C |
author_facet | Brix, Thomas H Hegedüs, Laszlo Hallas, Jesper Lund, Lars C |
author_sort | Brix, Thomas H |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7906640 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79066402021-02-26 Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism Brix, Thomas H Hegedüs, Laszlo Hallas, Jesper Lund, Lars C Lancet Diabetes Endocrinol Correspondence Elsevier Ltd. 2021-04 2021-02-19 /pmc/articles/PMC7906640/ /pubmed/33617779 http://dx.doi.org/10.1016/S2213-8587(21)00028-0 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Brix, Thomas H Hegedüs, Laszlo Hallas, Jesper Lund, Lars C Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism |
title | Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism |
title_full | Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism |
title_fullStr | Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism |
title_full_unstemmed | Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism |
title_short | Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism |
title_sort | risk and course of sars-cov-2 infection in patients treated for hypothyroidism and hyperthyroidism |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906640/ https://www.ncbi.nlm.nih.gov/pubmed/33617779 http://dx.doi.org/10.1016/S2213-8587(21)00028-0 |
work_keys_str_mv | AT brixthomash riskandcourseofsarscov2infectioninpatientstreatedforhypothyroidismandhyperthyroidism AT hegeduslaszlo riskandcourseofsarscov2infectioninpatientstreatedforhypothyroidismandhyperthyroidism AT hallasjesper riskandcourseofsarscov2infectioninpatientstreatedforhypothyroidismandhyperthyroidism AT lundlarsc riskandcourseofsarscov2infectioninpatientstreatedforhypothyroidismandhyperthyroidism |